annual cash & cash equivalents:
$222.50M-$63.82M(-22.29%)Summary
- As of today (September 16, 2025), MIRM annual cash & cash equivalents is $222.50 million, with the most recent change of -$63.82 million (-22.29%) on December 31, 2024.
- During the last 3 years, MIRM annual cash & cash equivalents has risen by +$191.16 million (+609.96%).
- MIRM annual cash & cash equivalents is now -22.29% below its all-time high of $286.33 million, reached on December 31, 2023.
Performance
MIRM Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$304.55M+$26.88M(+9.68%)Summary
- As of today (September 16, 2025), MIRM quarterly cash & cash equivalents is $304.55 million, with the most recent change of +$26.88 million (+9.68%) on June 30, 2025.
- Over the past year, MIRM quarterly cash & cash equivalents has increased by +$26.18 million (+9.41%).
- MIRM quarterly cash & cash equivalents is now -7.70% below its all-time high of $329.95 million, reached on June 30, 2023.
Performance
MIRM quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MIRM Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.3% | +9.4% |
| 3 y3 years | +610.0% | +143.7% |
| 5 y5 years | +1758.8% | +103.9% |
MIRM Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.3% | +694.6% | -7.7% | +143.7% |
| 5 y | 5-year | -22.3% | +1758.8% | -7.7% | +143.7% |
| alltime | all time | -22.3% | +1758.8% | -7.7% | +515.3% |
MIRM Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $304.55M(+9.7%) |
| Mar 2025 | - | $277.67M(-0.9%) |
| Dec 2024 | $222.50M(-22.3%) | $280.31M(-1.5%) |
| Sep 2024 | - | $284.44M(+2.2%) |
| Jun 2024 | - | $278.37M(-8.1%) |
| Mar 2024 | - | $302.84M(+5.8%) |
| Dec 2023 | $286.33M(+922.5%) | $286.33M(-6.4%) |
| Sep 2023 | - | $306.03M(-7.3%) |
| Jun 2023 | - | $329.95M(+149.8%) |
| Mar 2023 | - | $132.07M(-12.9%) |
| Dec 2022 | $28.00M | $151.72M(-18.1%) |
| Sep 2022 | - | $185.35M(+48.3%) |
| Jun 2022 | - | $124.95M(-10.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $139.91M(-10.6%) |
| Dec 2021 | $31.34M(-77.9%) | $156.54M(-17.6%) |
| Sep 2021 | - | $190.03M(-15.1%) |
| Jun 2021 | - | $223.85M(+5.0%) |
| Mar 2021 | - | $213.11M(-8.1%) |
| Dec 2020 | $142.09M(+1087.0%) | $231.82M(+73.3%) |
| Sep 2020 | - | $133.75M(-10.4%) |
| Jun 2020 | - | $149.34M(-6.4%) |
| Mar 2020 | - | $159.53M(+36.7%) |
| Dec 2019 | $11.97M(-77.0%) | $116.66M(-7.6%) |
| Sep 2019 | - | $126.26M(+50.0%) |
| Jun 2019 | - | $84.19M(+70.1%) |
| Mar 2019 | - | $49.49M |
| Dec 2018 | $51.96M | - |
FAQ
- What is Mirum Pharmaceuticals, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Mirum Pharmaceuticals, Inc.?
- What is Mirum Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
- What is Mirum Pharmaceuticals, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Mirum Pharmaceuticals, Inc.?
- What is Mirum Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
What is Mirum Pharmaceuticals, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of MIRM is $222.50M
What is the all time high annual cash & cash equivalents for Mirum Pharmaceuticals, Inc.?
Mirum Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $286.33M
What is Mirum Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, MIRM annual cash & cash equivalents has changed by -$63.82M (-22.29%)
What is Mirum Pharmaceuticals, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of MIRM is $304.55M
What is the all time high quarterly cash & cash equivalents for Mirum Pharmaceuticals, Inc.?
Mirum Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $329.95M
What is Mirum Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, MIRM quarterly cash & cash equivalents has changed by +$26.18M (+9.41%)